This means a person has developed antibodies against the HIV virus in their body. It shows that they have been exposed to HIV at some point, but it doesn't necessarily mean they have an active infection or AIDS. It's a sign of exposure, not necessarily disease.
Every report comes from a Lived member, sent anonymously.
Have you tried Biktarvy (Bictegravir / Emtricitabine / Tenofovir Alafenamide) for HIV Positive?
Being HIV positive means a test has found evidence of HIV, the human immunodeficiency virus, in a person's body. Most HIV tests look for antibodies (proteins the immune system makes in response to the virus), a piece of the virus itself, or both, which is why the medical term for this result is HIV seropositivity. Once a positive result is confirmed with follow-up testing, it means the person has HIV infection. The body cannot clear the virus on its own, so HIV is lifelong. HIV damages the immune system by destroying CD4 cells, a type of white blood cell that helps organize the body's defense against infection. Many people feel well for years, but without treatment the virus gradually wears down immunity and can lead to AIDS (acquired immunodeficiency syndrome), the late stage of infection, when serious infections and certain cancers take hold. Today, daily treatment keeps the virus under control, and people who start it promptly and stay on it can expect to live long, healthy lives.
HIV passes between people only through specific body fluids from someone whose virus is detectable in their blood: blood, semen and pre-seminal fluid, rectal fluids, vaginal fluids and breast milk. To cause infection, the virus has to reach the bloodstream through a mucous membrane (such as the lining of the rectum or vagina), broken skin or an injection. In the United States, it spreads most often through anal or vaginal sex without a condom or HIV prevention medicine, and through sharing needles or other injection equipment. Anal sex carries more risk than vaginal sex. HIV can also pass to a baby during pregnancy, birth or breastfeeding, although treatment has made this uncommon in the US. HIV is not spread through saliva or by eating food handled by someone with HIV, and screening has made infection from blood transfusions or donated organs extremely rare in the US. Having another sexually transmitted infection (STI) raises the chance of acquiring or passing on HIV. New diagnoses are more common among gay and bisexual men and among Black and Hispanic Americans, and factors such as stigma, income and access to care shape who is affected, but anyone can acquire HIV.
HIV testing uses blood from a vein, a finger-prick sample or oral fluid. The most widely used tests look for both HIV antibodies and an HIV antigen (a protein from the virus that appears in the blood before antibodies do). Rapid tests and home self-tests give a result in about 20 to 30 minutes, while lab tests take a few days. A single positive screening test is not a diagnosis. Every positive result must be confirmed with additional testing in a health care setting; when blood goes to a lab, the lab usually runs the follow-up test on the same sample. Confirmation also matters because people who have taken part in an HIV vaccine study can test positive on antibody tests from the vaccine alone, without having HIV. No test can detect HIV right after infection. This gap, called the window period, ranges from about 10 to 90 days depending on the test. A nucleic acid test (NAT), which looks for the virus's genetic material, can usually find infection 10 to 33 days after exposure; an antibody and antigen lab test, 18 to 45 days; antibody-only tests can take up to 90 days. A negative result soon after a possible exposure therefore needs repeating. After diagnosis, two blood tests become the core of care. The CD4 count measures how many CD4 cells are in a small sample (a cubic millimeter) of blood: healthy adults usually have at least 500, and a count below 200 means HIV has progressed to AIDS. Developing certain serious infections, called opportunistic infections, also defines AIDS whatever the count. The viral load measures how much HIV is in the blood and shows how well treatment is working. A drug-resistance test checks whether the person's strain of HIV is resistant to any medicines, which guides the choice of treatment.
Treatment for HIV is antiretroviral therapy (ART), a combination of medicines that controls the virus by keeping it from multiplying. It is recommended for everyone with HIV, regardless of how long they have had it or how well they feel, and it should start as soon as possible after diagnosis, sometimes on the same day. Starting promptly matters most during early infection, during pregnancy and for anyone who already has AIDS. A first regimen usually combines three medicines from at least two drug classes, and many people take them as a single daily pill. Biktarvy, which combines bictegravir, emtricitabine and tenofovir alafenamide, is one widely used example. For people whose virus is already well controlled on pills and who meet specific criteria, Cabenuva (long-acting cabotegravir and rilpivirine) replaces daily pills with injections given by a clinician every month or every two months. The choice depends on resistance testing, other health conditions, possible interactions with other medicines, pregnancy plans and what fits the person's routine. ART is not a cure, because the virus stays in the body. Its aim is viral suppression, a viral load below 200 copies per milliliter of blood, and ideally an undetectable level (usually fewer than 20 copies on a standard test). Almost everyone who takes their medicine as prescribed becomes undetectable, usually within six months. This protects the immune system, lets the CD4 count recover, and means the person will not pass HIV to sexual partners, a principle known as undetectable equals untransmittable (U=U). In pregnancy, daily treatment through delivery, plus medicine given to the baby for several weeks after birth, can lower the chance of passing HIV to the baby to 1% or less. Today's HIV medicines cause fewer and milder side effects than older ones. Nausea, diarrhea, headache, trouble sleeping and fatigue are among the more common, and some ease within a few weeks. The main practical demand is consistency: skipping doses or stopping and restarting lets the virus rebound and can create drug resistance, which narrows future options. Depending on the CD4 count, a clinician may also prescribe medicines that prevent specific infections.
With steady treatment, HIV is a manageable long-term condition. In the US, most people living with HIV never develop AIDS, because treatment stops the disease from progressing. The contrast with no treatment is stark: without HIV medicine, people with AIDS typically survive about three years. Treatment still helps people diagnosed late, but those who start soon after infection benefit most. Daily life centers on taking medicine reliably and staying in care. Blood tests every few months track the viral load and CD4 count, and once both are stable, follow-up often settles into a predictable rhythm. An occasional low-level positive viral load result, called a blip, does not necessarily mean treatment is failing. Ongoing care also includes routine medical and dental visits, recommended vaccines and health screenings. Not smoking matters more than usual, because people with HIV who smoke have a higher risk of certain cancers and infections, and heavy drinking or drug use can harm the liver and make HIV medicine work less well. Having HIV does not rule out having children; treatment protects both parent and baby. A diagnosis also brings practical and emotional questions, such as whom to tell, how to talk with partners and how to pay for care. Insurers are required to cover some HIV medicines, and state, federal and private programs help people without coverage. Counselors, support groups and HIV service organizations can help with both the logistics and the stress, and an HIV care team can connect people to them.
If a home or rapid test is positive, see a health care provider for confirmatory testing; once HIV is confirmed, the next step is starting treatment as soon as possible. Anyone with HIV who becomes pregnant, or is planning to, should tell their HIV care team right away so treatment can also protect the baby. Contact your care team as soon as possible if you have stopped your HIV medicine, are missing doses, or have side effects bad enough that you are thinking of stopping; talk to them before skipping any doses. Let them know about new symptoms or health problems, since a weakened immune system can make infections more serious. If a partner may have been exposed to HIV through sex while your viral load was detectable, or through shared needles, they should talk to a health care provider the same day about post-exposure prophylaxis (PEP). PEP is a short course of HIV medicine that can prevent infection, but only if it is started within 72 hours, and the sooner the better.
Last reviewed • Oct 2026
Educational content, not medical advice.
The best medication I learned to have that helps is Biktarvy it suppresses the virus and gets your cell count up